{
  "profile_url": "https://www.moffitt.org/research-science/researchers/mokenge-malafa",
  "last_updated": "2025-10-21T16:37:23.311772",
  "researcher_id": "2725",
  "degrees": [
    "MD"
  ],
  "title": "",
  "primary_program": "Gastrointestinal Oncology",
  "research_program": "Molecular Medicine Program",
  "overview": "Discovery, identification, and characterization of the role of bioactive vitamin E compounds in regulating biological processes in the cancer cell.",
  "research_interests": [
    "Dr. Malafa's research group focuses on vitamin E signaling pathways and biomarkers in pancreatic cancer. Previously his group demonstrated vitamin E succinate inhibition of oncogenic Ras signaling pathways (Donapaty et al, Molecular Cancer Therapeutics, 2006). Following up on this work, his group identified the most bioactive vitamin E analogue, delta-tocotrienol, in pancreatic cancer cells and reported that therapeutic levels of delta-tocotrienol was achieved in mice pancreas following oral administration. Dr. Malafa and his collaborators have embarked on a strategy to comprehend signaling pathways active in pancreatic cancer cells and targeted by vitamin E delta-tocotrienol, employing affinity chromatography, chemical proteomics, and mass spectrometry to identify direct interacting proteins. They identified nearly 20 different protein targets of delta-tocotrienol. One of the targets, hCAS, was shown to be a relevant target of delta-tocotrienol action and a valid novel target in pancreatic and colorectal cancers. Future directions in the lab consist of using small molecule-protein binding interactions to define the biochemical target(s) of vitamin E tocotrienol anticancer activity and thereby identify novel targets for the prevention of malignancy\n  *"
  ],
  "associations": [
    "Gastrointestinal Oncology",
    "Drug Discovery",
    "Cancer Chemoprevention Research Interest Group",
    "Molecular Medicine Program"
  ],
  "education": [
    {
      "type": "Medical School",
      "institution": "University of Wisconsin, Madison",
      "degree": "MD"
    },
    {
      "type": "Residency",
      "institution": "Medical College of Ohio, Toledo",
      "specialty": "General Surgery"
    },
    {
      "type": "Residency",
      "institution": "Medical College of Ohio",
      "specialty": "General Surgery"
    },
    {
      "type": "Fellowship",
      "institution": "City of Hope National Medical Center",
      "specialty": "Surgical Oncology"
    },
    {
      "type": "Fellowship",
      "institution": "City of Hope National Medical Center",
      "specialty": "Surgical Oncology"
    }
  ],
  "publications": [
    {
      "title": "The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma",
      "pubmed_id": "40553455",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "Davis EW, Park MA, Basinski TL, Arnoletti JP, Bloomston M, Carson TL, Biachi De Castria T, Chen DT, Cortizas EM, Crowder SL, Genilo-Delgado M, Douglas WG, Huguet KL, Jiang K, Hodul PJ, Karolak A, Kim DW, Koomen JM, Menon AA, Mo Q, Mok SR, Molina-Vega MA, Moreno-Urazan L, Ahmed S, Parker NH, Pimiento JM, Rasool G, Sparks LM, Stewart PA, Tassielli AF, Teer JK, Trevino JG, Velanovich V, Wang X, Whelan CJ, Judge SM, Judge AR, Fleming JB, Malafa MP, Jeong D, Permuth JB",
      "journal": "Cancer Epidemiol Biomarkers Prev"
    },
    {
      "title": "Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy",
      "pubmed_id": "40507279",
      "pmc_id": "PMC12153592",
      "year": "2025",
      "publication_date": "2025 May",
      "authors": "Yu J, Laborde JM, Park R, Shahzad M, Kim Y, Cheon J, Imanirad I, Kim RD, Biachi de Castria T, Nardella NL, Malafa M, Denbo JW, Fleming JB, Hoffe SE, Frakes JM, Sinnamon AJ, Pimiento JM, Hodul PJ, Kim DW",
      "journal": "Cancers (Basel)"
    },
    {
      "title": "Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma",
      "pubmed_id": "39989973",
      "pmc_id": "PMC11844656",
      "year": "2025",
      "publication_date": "2025 Feb",
      "authors": "Permuth J, Park M, Davis E, Alhassan S, Arnoletti J, Basinski T, McKee A, Bloomston M, Carson T, de Castria TB, Chen DT, Cortizas E, Crowder S, Delgado MG, Douglas W, Fleming J, Hodul P, Huguet K, Jiang K, Kim DW, Koomen J, Luthra A, Malafa M, Menon A, Morales R, Merchant N, Meredith K, Mo Q, Molina-Vega M, Moreno-Urazan L, Olumoyin K, Parker N, Pimiento J, Rasool G, Rejniak K, Sansil S, Sparks L, Stewart P, Tassielli A, Teer J, Tran DV, Trevino J, Velanovich V, Whelan C, Jeong D, Judge S, Judge A",
      "journal": "Res Sq"
    },
    {
      "title": "Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer",
      "pubmed_id": "40846751",
      "pmc_id": "PMC12373761",
      "year": "2025",
      "publication_date": "2025 Aug",
      "authors": "Bhatia R, Khan I, Li X, Gautam S, Seshacharyulu P, Alsafwani ZW, Bhyravbhatla N, Ponnusamy MP, Jain M, Malafa M, Bindu S, Gulzar A, Nair H, Batra SK, Kumar S",
      "journal": "NPJ Precis Oncol"
    },
    {
      "title": "To irradiate or electroporate: how should we ablate pancreatic cancer?",
      "pubmed_id": "40337766",
      "pmc_id": "PMC12056099",
      "year": "2025",
      "publication_date": "2025 Apr",
      "authors": "Bryant JM, Nakashima J, Khatri V, Malafa M, Frakes J, Hoffe S",
      "journal": "Transl Gastroenterol Hepatol"
    },
    {
      "title": "Emerging Trends in Gastrointestinal Cancer Targeted Therapies: Harnessing Tumor Microenvironment, Immune Factors, and Metabolomics Insights",
      "pubmed_id": "38759843",
      "year": "2024",
      "publication_date": "2024 Oct",
      "authors": "Rauth S, Malafa M, Ponnusamy MP, Batra SK",
      "journal": "Gastroenterology"
    },
    {
      "title": "Elevated Urinary Levels of Fungal and Environmental Toxins in Patients with Pancreatic Ductal Adenocarcinoma",
      "pubmed_id": "39419859",
      "pmc_id": "PMC11486816",
      "year": "2024",
      "publication_date": "2024 Oct",
      "authors": "Rodriguez VI, Mammadova J, Permuth JB, Luthra A, Pena L, Friedman M, Dam A, Cappelle S, Malafa MP, Hallmon C, Miranda C, Mok SRS",
      "journal": "J Gastrointest Cancer"
    },
    {
      "title": "The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma",
      "pubmed_id": "39597944",
      "pmc_id": "PMC11594810",
      "year": "2024",
      "publication_date": "2024 Nov",
      "authors": "Bryant JM, Nakashima J, Khatri VM, Sinnamon AJ, Denbo JW, Hodul P, Malafa M, Hoffe S, Frakes JM",
      "journal": "J Clin Med"
    },
    {
      "title": "Editorial Expression of Concern: Adenomatous polyposis coli (APC) regulates miR17-92 cluster through \u03b2-catenin pathway in colorectal cancer",
      "pubmed_id": "38378921",
      "year": "2024",
      "publication_date": "2024 Mar",
      "authors": "Li Y, Lauriola M, Kim D, Francesconi M, D'Uva G, Shibata D, Malafa MP, Yeatman TJ, Coppola D, Solmi R, Cheng JQ",
      "journal": "Oncogene"
    },
    {
      "title": "Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design",
      "pubmed_id": "38264869",
      "pmc_id": "PMC10988540",
      "year": "2024",
      "publication_date": "2024 Mar",
      "authors": "Hoffe SE, Aguilera TA, Parikh PJ, Ghaly MM, Herman JM, Caster JM, Kim DW, Costello J, Malafa MP, Moser EC, Kennedy EP, Terry K, Kurman M",
      "journal": "Future Oncol"
    }
  ],
  "grants": [
    {
      "description": "Title: Novel Therapy to Inhibit IPMN Progression  \nAward Number: 5R01CA263575-03  \nSponsor: National Cancer Institute (NCI)  \nMalafa, M. (PD/PI)",
      "title": "Novel Therapy to Inhibit IPMN Progression",
      "award_number": "5R01CA263575-03",
      "sponsor": "National Cancer Institute (NCI)",
      "source": "NCI",
      "investigators": [
        {
          "name": "Malafa, M.",
          "role": "PD/PI"
        }
      ]
    },
    {
      "description": "Title: Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations  \nAward Number: W81XWH-22-1-1022  \nSponsor: Department of Defense (DOD)  \nMalafa, M. (PD/PI)",
      "title": "Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations",
      "award_number": "W81XWH-22-1-1022",
      "sponsor": "Department of Defense (DOD)",
      "source": "DOD",
      "investigators": [
        {
          "name": "Malafa, M.",
          "role": "PD/PI"
        }
      ]
    },
    {
      "description": ""
    }
  ],
  "photo_url": "https://www.moffitt.org/globalassets/images/researchers_bio/MalafaMokenge_2725.jpg",
  "contact": {
    "contact_url": "https://eforms.moffitt.org/ContactResearchersForm?PERID=2725"
  },
  "content_hash": "9e225c77aea1bd140e398815e70d9cb13b89b95251620eb0043181dd5eadddc1",
  "researcher_name": "Mokenge Malafa",
  "department": "Drug Discovery"
}